Support For Drug E-Labeling Mixed, GAO Says

Law360, New York (July 9, 2013, 1:38 PM EDT) -- There is no consensus among doctors, drug companies and other pharmaceutical industry stakeholders on whether shifting to electronic drug labeling would be beneficial, the U.S. Government Accountability Office said Monday, suggesting the use of paper labeling is likely to continue.

According to the GAO’s study, mandated by last year’s U.S. Food and Drug Administration Safety and Innovation Act, the competing priorities and concerns of different stakeholder groups meant there was no consensus on whether electronic drug labeling was yet appropriate for use as a complete substitute...
To view the full article, register now.